Denosumab shared care guideline
In 2018, the APC agreed to adopt the Sheffield Denosumab 60mg/mL Injection (Prolia®) prescribing guidelines:
THE SHEFFIELD AREA PRESCRIBING COMMITTEE (sheffieldccg.nhs.uk)
In November 2022 guidance was developed on Denosumab (Prolia®) for Primary Care Clinicians; where patients have been previously initiated on Denosumab (Prolia®) as Shared Care by Barnsley Osteoporosis Service (patients are no longer under hospital supervision).
Date: 01 September 2022 to 31 December 2098
- TypeShared Care Guidelines
- Clinical Support Group
Dermatology, MSK and Rheumatology
Cancer, Palliative Care, Pain and Older People
- Part of
- Drug
- Traffic lightAmber (SCG)
- Conditions and indicators
- Clinical support by body system
- Due for review01 September 2027
- Link
- Bypass detail page
- Bypass detail page and
Do you want to add this to your CPD record?
Did you find this page helpful?